Organon (OGN) Misses Q4 EPS by 11c

Organon (NYSE: OGN) reported Q4 EPS of $0.81, $0.11 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.49 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting
• Freedom Broker Starts PBF Energy (PBF) at Hold